User menu

A survey of beta-lactam antibiotics and vancomycin dosing strategies in intensive care units and general wards in Belgian hospitals

Bibliographic reference Buyle, Franky M ; Decruyenaere, Johan ; De Waele, Jan ; Tulkens, Paul M. ; Van Audenrode, Thijs ; et. al. A survey of beta-lactam antibiotics and vancomycin dosing strategies in intensive care units and general wards in Belgian hospitals. In: European Journal of Clinical Microbiology & Infectious Diseases : an international journal on pathogenesis, diagnosis, epidemiology, therapy, and prevention of infectious diseases, Vol. 32, no.6, p. 763-768 (2013)
Permanent URL
  1. Craig William A, Basic pharmacodynamics of antibacterials with clinical applications to the use of β-lactams, glycopeptides, and linezolid, 10.1016/s0891-5520(03)00065-5
  2. Roberts Jason A., Webb Steven, Paterson David, Ho Kwok M., Lipman Jeffrey, A systematic review on clinical benefits of continuous administration of β-lactam antibiotics* : , 10.1097/ccm.0b013e3181a0054d
  3. Cataldo M. A., Tacconelli E., Grilli E., Pea F., Petrosillo N., Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis, 10.1093/jac/dkr442
  4. Wysocki M., Delatour F., Faurisson F., Rauss A., Pean Y., Misset B., Thomas F., Timsit J.-F., Similowski T., Mentec H., Mier L., Dreyfuss D., Continuous versus Intermittent Infusion of Vancomycin in Severe Staphylococcal Infections: Prospective Multicenter Randomized Study, 10.1128/aac.45.9.2460-2467.2001
  5. Van Gastel Evelyne, Costers Michiel, Peetermans Willy E., Struelens Marc J., Nationwide implementation of antibiotic management teams in Belgian hospitals: a self-reporting survey, 10.1093/jac/dkp470
  6. Claus B., Buyle F., Robays H., Vogelaers D., Importance of Infusion Volume and Pump Characteristics in Extended Administration of  -Lactam Antibiotics, 10.1128/aac.00754-10
  7. Geggie D., Moore D., Peripheral line dead space: an unrecognised phenomenon?, 10.1136/emj.2007.046250
  8. Sanford JP, Gilbert D, Chambers H, Eliopoulos GM, Moellering R, Saag M (2010) The Sanford guide to antimicrobial therapy, 2010–2011, 22nd edn. Belgian/Luxembourg version. Belgian/Luxembourg Working Party on Antimicrobial Therapy. ISBN 978-1-930808-63-3
  9. Federal Agency for Medicines and Health Products (FAMHP) Summary of product characteristics (SPC) for vancocin. Available online at: . Accessed 1 Oct 2012
  10. Federal Agency for Medicines and Health Products (FAMHP) Summary of product characteristics (SPC) for glazidim. Available online at: . Accessed 1 Oct 2012
  11. Van Herendael Bruno, Jeurissen Axel, Tulkens Paul M, Vlieghe Erika, Verbrugghe Walter, Jorens Philippe G, Ieven Margareta, Continuous infusion of antibiotics in the critically ill: The new holy grail for beta-lactams and vancomycin?, 10.1186/2110-5820-2-22
  12. Mouton Johan W, Vinks Alexander A, Continuous infusion of beta-lactams : , 10.1097/mcc.0b013e3282e2a98f
  13. Roberts Jason A., Kirkpatrick Carl M.J., Roberts Michael S., Dalley Andrew J., Lipman Jeffrey, First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis, 10.1016/j.ijantimicag.2009.10.008
  14. Ocampos-Martinez Eva, Penaccini Laura, Scolletta Sabino, Abdelhadii Ali, Devigili Alessandro, Cianferoni Silvia, de Backer Daniel, Jacobs Frédérique, Cotton Frédéric, Vincent Jean-Louis, Taccone Fabio Silvio, Determinants of early inadequate vancomycin concentrations during continuous infusion in septic patients, 10.1016/j.ijantimicag.2011.12.008
  15. Truong J., Levkovich B. J., Padiglione A. A., Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levels : Simple approach to improving vancomycin dosing, 10.1111/j.1445-5994.2011.02459.x
  16. Li Janice, Udy Andrew A., Kirkpatrick Carl M.J., Lipman Jeffrey, Roberts Jason A., Improving vancomycin prescription in critical illness through a drug use evaluation process: a weight-based dosing intervention study, 10.1016/j.ijantimicag.2011.08.017
  17. Rybak M., Lomaestro B., Rotschafer J. C., Moellering R., Craig W., Billeter M., Dalovisio J. R., Levine D. P., Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists, 10.2146/ajhp080434
  18. Taccone Fabio Silvio, Laterre Pierre-François, Dugernier Thierry, Spapen Herbert, Delattre Isabelle, Witebolle Xavier, De Backer Daniel, Layeux Brice, Wallemacq Pierre, Vincent Jean-Louis, Jacobs Frédérique, Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock, 10.1186/cc9091
  19. Roberts Jason A., Ulldemolins Marta, Roberts Michael S., McWhinney Brett, Ungerer Jacobus, Paterson David L., Lipman Jeffrey, Therapeutic drug monitoring of β-lactams in critically ill patients: proof of concept, 10.1016/j.ijantimicag.2010.06.008
  20. Udy Andrew A., Varghese Julie M., Altukroni Mahdi, Briscoe Scott, McWhinney Brett C., Ungerer Jacobus P., Lipman Jeffrey, Roberts Jason A., Subtherapeutic Initial β-Lactam Concentrations in Select Critically Ill Patients, 10.1378/chest.11-1671
  21. Pea F., Furlanut M., Negri C., Pavan F., Crapis M., Cristini F., Viale P., Prospectively Validated Dosing Nomograms for Maximizing the Pharmacodynamics of Vancomycin Administered by Continuous Infusion in Critically Ill Patients, 10.1128/aac.01149-08
  22. Carricajo A., Forgeot A., Morel J., Auboyer C., Zeni F., Aubert G., Ajustement de la posologie de la vancomycine administrée en perfusion continue chez des patients de réanimation, 10.1016/j.annfar.2009.12.002
  23. Spapen Herbert D, Janssen van Doorn Karin, Diltoer Marc, Verbrugghe Walter, Jacobs Rita, Dobbeleir Nadia, Honoré Patrick M, Jorens Philippe G, Retrospective evaluation of possible renal toxicity associated with continuous infusion of vancomycin in critically ill patients, 10.1186/2110-5820-1-26
  24. Ingram P. R., Lye D. C., Tambyah P. A., Goh W. P., Tam V. H., Fisher D. A., Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy, 10.1093/jac/dkn080
  25. Gupta A, Biyani M, Khaira A (2011) Vancomycin nephrotoxicity: myths and facts. Neth J Med 69:379–383
  26. Baririan N., Stability and compatibility study of cefepime in comparison with ceftazidime for potential administration by continuous infusion under conditions pertinent to ambulatory treatment of cystic fibrosis patients and to administration in intensive care units, 10.1093/jac/dkg134
  27. KUTI J, Pharmacokinetic properties and stability of continuous-infusion meropenem in adults with cystic fibrosis*1, 10.1016/s0149-2918(04)90051-3
  28. Berthoin K., Le Duff C. S., Marchand-Brynaert J., Carryn S., Tulkens P. M., Stability of meropenem and doripenem solutions for administration by continuous infusion, 10.1093/jac/dkq044